All Type of News
248 products, such as Cosentyx and Kynteles, newly registered
248 pharmaceutical products, including new drugs such as Cosentyx and Kynteles, will be newly registered in the list of health insurance benefits from the 1st of August.
The Ministry of Health and Welfare, on the 25t...
MFDS will strengthen global competitiveness of Korean clinical trials
The Ministry of Food and Drug Safety(MFDS) is seeking for plans to improve competitiveness for Korean clinical trials to the global level.
Korean clinical trials have been significantly improved in quality and quanti...
How to evaluate and report safety for drug clinical trials?
A guideline for safety evaluation and report was prepared for pharmaceutical companies to use at drug clinical trials.
Pharmaceutical companies, clients for clinical trial, must have a person taking in charge of moni...
Novo Nordisk acquires Korean approval of ‘Saxenda,’ GLP-1 analogue obesity treatment
Novo Nordisk Korea(President Rana Azfar Zafar) announced that Saxenda(generic name: liraglutide), its new obesity therapy, was approved from the Ministry of Food and Drug Safety on the 21st.
Saxenda is the world’s ob...
Congested development of generic drugs with rapid decrease in bioequivalently-tested products
It was observed there were 329 pharmaceutical products newly approved with bioequivalence test this year, decreased by a half compared to the same period of the last year.
According to the Ministry of Food and Drug S...
Approvals for ‘Tamifly’ generics about to pour out for bioequivalence tests
Approvals for generics of ‘Tamiflu,’ a influenza virus treatment whose patent is expiring on the 22nd of August, are pouring out.
According to the Ministry of Food and Drug Safety(MFDS) on the 25th, 15 generic drugs ...
Prosecution soon to reveal final rebate investigation result, enlarging intense in pharmaceutical and distribution fields
The Eastern Branch of Busan District Public Prosecutors’ Office, which has strongly investigated illegal rebates, has brought tension to pharmaceutical companies and pharmaceutical distribution companies for the inves...
Chong Kun Dang’s momentum with launch of Sengla after CendomChong Kun Dang(CEO Young-Joo Kim) released ‘Sengla,’ a erectile dysfunction treatment, on the 25th to enlarge its market.
Sildenafil, a Sengla’s main substance, shows excellent...
|
Hanmi creates lineup with Amosartan family, challenging annul KRW 100 million sales
Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) acquired approvals for 2 products of 2-substance combination drug containing the substance of Amosartan, the top sales product. Hanmi is planning to continue the Amosartan...
Huons acquires ‘generic’ approval of 0.9% Sodium Chloride Injection USP 5mL/10mL from U.S. FDAHuons(CEO Gi-An Eom), a subsidiary of Huons Global, announced on the 24th that 0.9% Sodium Chloride Injection USP 5mL/10mL acquired a generic drug approval(ANDA) from the U.S. F...
|
